Prevalence of anemia and mortality among anemic patients with COVID-19 in a tertiary care setting in Nepal
DOI:
https://doi.org/10.3126/jpahs.v10i2.59292Keywords:
anemia, Covid-19, hemoglobin, prevalenceAbstract
Introduction: The COVID-19 pandemic first detected in December 2019 has claimed so many lives globally as well as in Nepal. Inflammatory changes in SARS-CoV-2 infection can lead to anemia. This study aims to find the prevalence of anemia and mortality among anemic patients in COVID patients admitted to a tertiary care centre in Nepal.
Method: A descriptive cross-sectional study with data collected retrospectively between May 2021 to February 2022 on patients with proven COVID-19 admitted to Patan Hospital.
Result: Among 890, anemia was prevalent in 296(33.25%) (CI 95%, 30.17-36.35) patients which was more among the female population. The mean hemoglobin was 10.68±1.62 g/dl in anemic patients. Mild anemia was present in 215(72.6%) patients followed by moderate in 64(21.6%) patients and severe in 17(5.8%) patients. The mortality in anemic patients was 43(14.5%).
Conclusion: One third of COVID-19 patients admitted to Patan Hospital had anemia which was found to be similar to studies done in similar setting. One in four COVID-19 patients with anemia had died was found to be lower than other studies done in similar settings.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
© Journal of Patan Academy of Health Sciences
Submission of the manuscript means that the authors agree to assign exclusive copyright to JPAHS. All authors must sign a Copyright Transfer and Author Agreement form upon submission of the manuscript to the Journal. The work shall not be published elsewhere in any language without the written consent of JPAHS. The articles published in this journal are protected by copyright which covers translation rights and the exclusive rights to reproduce and distribute all of the articles printed in the journal.